Clinical trial Recruiting at 1 site Observational Ages 18 and up

Motivation and reward learning in people with chronic neuropathic pain

Official title: Motivational Behavioral and Functional MRI Impairment in Patients With Chronic Neuropathic Pain

Run by Fondation Ophtalmologique Adolphe de Rothschild · NCT05701852 · Data updated 2026-11-12

It tests whether people with chronic neuropathic pain have a reduced capacity for reward learning by measuring behavior and brain activity during a reward-learning task.

More Chronic Pain trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment50 (estimated)
SponsorFondation Ophtalmologique Adolphe de Rothschild
Research network
Locations1 site (Paris)
StatusRecruiting
StartedDecember 19, 2023
Main results expectedMay 2027
Study endsMay 2027
Registry record updatedJanuary 5, 2026
Trial IDNCT05701852 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults with chronic neuropathic pain treated at the neurosurgery department or CETD of the sponsoring center who can undergo MRI, do behavioral tasks, and do not have major depression, neuroinflammatory/degenerative disease, or high-dose opioid use.

Probably not a fit

People with clinical depressive syndrome, high-dose opioid treatment, significant cognitive impairment, or any absolute contraindication to MRI are excluded and therefore unlikely to benefit from the protocol's findings or participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study compares people with chronic neuropathic pain to age- and sex-matched healthy controls using a computerized reward-learning task performed during functional MRI. Researchers will measure behavioral performance on the task and corresponding BOLD responses in key reward-system regions to probe alterations in reward circuitry. The work targets the dopaminergic-dependent mechanisms thought to underlie motivational deficits in chronic pain. Standard exclusions include neurodegenerative or inflammatory neurological disease, clinical depressive syndrome, high-dose opioid use, cognitive inability to perform tasks, and contraindications to MRI.

Why it matters

Potential benefit: If successful, the findings could clarify why some patients with chronic neuropathic pain have motivational deficits and guide development of treatments targeting reward processing.

How similar studies have gone: Previous fMRI and behavioral studies have reported altered reward processing in chronic pain, so this approach builds on existing evidence rather than being entirely novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* For cases: patients managed in the neurosurgery department or at CETD for chronic neuropathic pain, of central or peripheral origin.
* For controls: matched to a case on age (±5 years) and sex

Exclusion Criteria:

* Neurodegenerative or inflammatory neurological pathology
* Clinical depressive syndrome
* High doses of opioid treatment (greater than 100 mg/day of morphine equivalent)
* Impaired judgment or inability to receive information that does not allow the performance of behavioral tasks
* Absolute contraindication to MRI (e.g. pacemaker, implantable pacemaker, metallic intra-orbital foreign body)

Where it's running

  • Hôpital Fondation Adolphe de Rothschild
    Paris, France
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work

    This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.

    Recruiting at 2 sites Karolinska Institutet · Luleå, Norrbotten County and 2 other locations · NCT07924774

  • One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital

    A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.

    Recruiting Ottawa Hospital Research Institute · Ottawa, Ontario · NCT07919626

  • Meaning-Based Psychotherapy for Adults with Chronic Pain

    This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.

    Recruiting Hospital Clinico Universitario San Cecilio · Granada, Granada · NCT07915440

  • How chronic pain changes over time in kids with Duchenne Muscular Dystrophy

    This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.

    Recruiting Antalya Training and Research Hospital · Antalya, Antalya · NCT07892196

  • CBD for Opioid Dependence and Pain on Buprenorphine

    This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.

    Recruiting Early Phase 1 Yale University · West Haven, Connecticut · NCT07886606

  • Cebranopadol for opioid withdrawal in adults with chronic pain

    This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.

    Recruiting at 2 sites Phase 2 Adneuris Therapeutics, Inc. · North Canton, Ohio and 1 other locations · NCT07874620

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.